About 193,000 results
Open links in new tab
  1. Unproven

    In a decision that shocked some observers, key advisers to the US Food and Drug Administration (FDA) voted that the effectiveness of the party drug MDMA for treating post-traumatic stress disorder is unproven. Members of an independent scientific advisory committee voted 9 to 2 that human trials of MDMA did not prove its efficacy.
    www.nature.com/articles/d41586-024-01622-3
    www.nature.com/articles/d41586-024-01622-3
    Was this helpful?
  2. People also ask
  3. FDA advisers reject MDMA as treatment for PTSD : Shots - NPR

  4. FDA declines to approve novel MDMA therapy to treat PTSD, with …

  5. Why FDA Panel Rejected MDMA Therapy—And What’s Next For

  6. MDMA therapy for PTSD rejected by FDA panel - Nature

    WEBJun 5, 2024 · Scientific advisers to the US Food and Drug Administration rejected the effectiveness and safety of MDMA treatment for post-traumatic stress disorder. They raised concerns about the study design, the role of …

  7. FDA Panel Rejects Use of MDMA for Treatment of PTSD - The New …

  8. FDA advisers vote against first MDMA therapy to treat PTSD

  9. FDA rejects MDMA-assisted therapy for PTSD - NBC News

  10. FDA rejects MDMA for treating PTSD, calls for redo of study, …

  11. FDA rejects MDMA-assisted therapy for PTSD treatment – a drug ...